The FDA still has specific criteria a substance must meet to be eligible for compounding, and the Pharmacy Compounding Advisory Committees July 2026 review will determine whether any of these peptides will be officially cleared
Study 5: Phase 2b clinical study, failure in obesity Citation: Metabolic Pharmaceuticals Phase 2b trial (2007), not fully published
How to interpret the labs Autoimmune disease, infection risk, immune medications, and copper exposure from supplements should be reviewed clinically
Review our peptide sourcing guide
A peptide that supports metabolism or hormone function, for example, may require extra caution in someone with an endocrine disorder or a history of adverse drug reactions
Follow these steps carefully when mixing your peptide